Gadobutrol (Gadavist) is a gadolinium-based contrast agent (GBCA). Radiologists use it to see inside of your body on a magnetic resonance imaging (MRI) scan. Gadobutrol (Gadavist) injected intravenously (into the veins) before imaging and can be used for both adults and children. The most common side effects include headache and nausea. Rarely, gadobutrol (Gadavist) can cause severe thickening of your skin and other organs. The risk is higher if you have kidney problems, including sudden kidney injury.
Gadobutrol (Gadavist) is a contrast dye containing gadolinium. It's used with an MRI scan to help your radiologist see where abnormal tissues are in your body to better diagnose your medical condition.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Before you go in for your MRI scan, your radiology team will prepare you with specific instructions to help you get ready for the appointment. On your imaging day, a nurse or radiologist will inject gadobutrol (Gadavist) into the veins before your scan. Your MRI appointment will likely take longer than an hour. Though rare, some people have developed an allergic reaction from gadobutrol (Gadavist), sometimes days after receiving the contrast agent. Get medical help right away if you notice symptoms of an allergic reaction, including trouble breathing or rash.
Your body gets rid of gadobutrol (Gadavist) through the kidneys. Based on the half-life of gadobutrol (Gadavist), it takes about 12 hours for most of this contrast agent to leave the body after a dose. But this time frame can differ depending on other factors, such as your age and kidney health. One thing to note is that trace amounts of gadobutrol (Gadavist) can stay in the body up to several months and years. It's unclear how this might affect the body over time. To lower the risk of possible harm, your radiology team will try to minimize using gadobutrol (Gadavist) for future imaging studies whenever possible. Talk with your care team if you have concerns about receiving gadobutrol (Gadavist).
Gadobutrol (Gadavist) hasn’t been studied in pregnant people, but animal studies show that this medication can cause harm to developing babies. If you’re pregnant or planning on becoming pregnant, talk to your radiology team so you can discuss the risks of receiving gadobutrol (Gadavist) for your MRI scan.
Gadobutrol (Gadavist) contains a heavy metal called gadolinium. So if you're allergic to other gadolinium-based contrast agents (GBCAs), such as Dotarem (gadoterate meglumine) or Omniscan (Gadodiamide), make sure to tell your radiology team before receiving gadobutrol (Gadavist). Depending on how severe your reaction to gadolinium is, your radiologist will decide if it's safe for you to receive gadobutrol (Gadavist) or if you should receive a contrast dye that doesn't contain gadolinium.
Maybe. Some people with kidney problems who get gadobutrol (Gadavist) can develop a medical condition called nephrogenic systemic fibrosis (NSF). This can lead to severe thickening of the skin, muscles, and other organs. The risk is typically higher for people with chronic severe kidney disease or sudden kidney injury. Before your imaging, your radiologist will order blood work to check on your kidney health. Let your care team know if you have any symptoms of kidney injury in the days leading up to or after your imaging, such as making less urine, swelling in the ankles and legs, and tiredness. Also, let your care team know about your medical history since certain health conditions, such as diabetes and high blood pressure, can raise your risk of kidney injury.
Gadobutrol (Gadavist) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Some people with kidney problems have developed a medical condition called nephrogenic systemic fibrosis (NSF) after receiving gadobutrol (Gadavist). This happens because their kidneys aren't working properly to get rid of gadobutrol (Gadavist) from the body, which can lead to toxicity. NSF can cause severe thickening of the skin, muscles, and other organs in your body, which can be life-threatening.
Before your imaging, your radiologist will order blood work to check on your kidney health. Let your care team know if you have any symptoms of kidney injury in the days leading up to or after your imaging, such as making less urine, swelling in the ankles and legs, and tiredness.
Your radiologist might not use gadobutrol (Gadavist) for your MRI if you have kidney problems, unless there aren't any safer options available.
Serious allergic reactions to gadobutrol (Gadavist) are possible, including life-threatening reactions like anaphylaxis (e.g., closing of the throat). These reactions are most common within the first 30 minutes of injection, but they can also happen several days after. During your appointment, your healthcare team will monitor you for signs and symptoms of allergic reaction. If you notice dizziness, difficulty breathing, or swelling of the lips or tongue after receiving gadobutrol (Gadavist) (even after you're already home from your appointment), get medical help right away.
Certain contrast agents that contain gadolinium, such as gadobutrol (Gadavist), can stay in your body for several months or years. Most commonly, gadobutrol (Gadavist) can build up in your bone, but it can also build up in the brain, skin, kidneys, liver, and spleen. More research is needed to understand the kind of impact the buildup of gadolinium can have on different parts of the body. But there's a risk that it can cause harm. If you've received multiple doses of gadolinium medication in the past, if you're pregnant, or if you've a history of inflammatory conditions, talk to your radiology team before receiving gadobutrol (Gadavist).
Gadobutrol (Gadavist) can sometimes cause irritation around the injection site when the medication is leaked out of the veins. If you experience itching, pain, and redness around the injection site, let your radiology team know.
Each mL of injection contains 1 millimole (mmol) of gadobutrol (Gadavist).
Your radiologist will determine your dose of gadobutrol (Gadavist) based on your body weight. The typical dose is 0.1 mL/kg of body weight injected into the veins on imaging day by a nurse or a radiologist.